Bandhan Equity Saving Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹1,000

Bandhan Equity Saving Growth Direct Plan

NAV
₹33.0240
+0.21%
(22 Nov)
AUM
194 Cr
TER
0.18%
Risk
Low to Moderate Risk
Rating
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+22.4%
+20.0%
+16.5%
+15.9%
+13.6%
+10.5%
3Y
+13.3%
+10.7%
+11.4%
+11.5%
+8.9%
+7.6%
5Y
+13.9%
+11.1%
+14.4%
+11.9%
+10.0%
+9.0%
ALL
+10.4%
+10.9%
+10.2%
+10.3%
+8.0%
+7.7%
VOL
6.2%
6.3%
6.0%
5.7%
-
4.9%
TER
0.6%
0.7%
0.6%
0.7%
-
0.2%
AUM
₹548 Cr
₹341 Cr
₹990 Cr
₹7,804 Cr
-
₹194 Cr
INFO
1.67
1.72
1.71
1.82
-
1.58
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Bandhan Equity Saving (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Aug
Top holdings
Cash Offset For Derivatives
56.8%
Bandhan Liquid Dir Gr
6.7%
7.18% Govt Stock 2037
5.1%
Bandhan Money Manager Dir Gr
5.0%
Future on Aurobindo Pharma Ltd
4.9%
Aurobindo Pharma Ltd
4.9%
Future on IndusInd Bank Ltd
4.6%
IndusInd Bank Ltd
4.5%
State Bank Of India September 2024 Future
4.3%
State Bank of India
4.3%
Top industry exposure
Financial Services
23.6%
Basic Materials
8.6%
Healthcare
7.3%
Technology
7.1%
Consumer Defensive
6.5%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
50%
Lock-in period
-
Exit load
• 0.25% for redemption within 7 days
Fund objective
To generate income by predominantly investing in arbitrage opportunities in the cash and derivatives segments of the equity markets along with debt and money market instruments and to generate long-term capital appreciation by investing a portion of the Scheme’s assets in equity and equity related instruments.
Fund manager(s)
Harshal Joshi
Viraj Kulkarni
Brijesh Shah
Nemish Sheth
Ritika Behera
Gaurav Satra

FAQs